表紙
市場調査レポート

冠状動脈血管痙攣:世界の治験レビュー

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 214949
出版日 ページ情報 英文 57 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
冠状動脈血管痙攣:世界の治験レビュー Coronary Vasospasm Global Clinical Trials Review, H2, 2014
出版日: 2014年08月20日 ページ情報: 英文 57 Pages
概要

当レポートでは、世界各国における冠状動脈血管痙攣の臨床試験について調査し、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、各企業・機関での進行状況といった情報を盛り込んで、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 冠状動脈血管痙攣
    • レポートガイダンス
  • 臨床試験 地域別
  • 臨床試験 国別
    • 臨床試験に寄与している上位国 − アジア太平洋地域
    • 臨床試験に寄与している上位国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
  • 臨床試験 − G7 諸国
  • 臨床試験 − G7 諸国 治験ステータス別
  • 臨床試験 相別
    • 進行中の治験 相別
  • 臨床試験 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Robert Bosch Gesellschaft fur medizinische Forschung mbH
      • Robert Bosch Medical Center
      • 熊本大学
      • University of Nebraska
      • The University of Edinburgh
      • University Hospital Basel
      • Washington University School of Medicine
  • 5件の主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2309CTIDB

GlobalData's clinical trial report, "Coronary Vasospasm Global Clinical Trials Review, H2, 2014" provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Vasospasm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Vasospasm
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Coronary Vasospasm Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Japanese Coronary Spasm Association
      • Clinical Trial Overview of Japanese Coronary Spasm Association
      • Robert Bosch Medical Center
      • Clinical Trial Overview of Robert Bosch Medical Center
      • Kyorin University
      • Clinical Trial Overview of Kyorin University
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • National Institute of Health and Medical Research
      • Clinical Trial Overview of National Institute of Health and Medical Research
      • University of Nebraska
      • Clinical Trial Overview of University of Nebraska
      • Korea University
      • Clinical Trial Overview of Korea University
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*

List of Figures

  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • GlobalData Methodology
Back to Top